SpyGlass Pharma, Inc. (SGP)
23.87
+3.12
(+15.04%)
USD |
NASDAQ |
Apr 13, 16:00
24.27
+0.40
(+1.68%)
After-Hours: 05:48
SpyGlass Pharma EPS Diluted (Quarterly) : -0.3756 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Select Medical Holdings Corp. | 0.1627 |
| Champions Oncology, Inc. | -0.0201 |
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Akari Therapeutics Plc | 0.00 |
| Intellia Therapeutics, Inc. | -0.8263 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.56M |
| Total Expenses (Quarterly) | 12.56M |
| Enterprise Value | 893.97M |
| Earnings Yield | -1.57% |